Share on Google Plus Share on Twitter Share on Facebook Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend

Printer Friendly Page Save As Favorite View Favorites (# of views)   1 comment
Sci Tech

Barbara Walters' Television Special Highlights Role Advanced Cell Technology's Embryonic Stem Cells Breakthroughs

By Stephen Fox (Business Wire Press Release)  Posted by Stephen Fox (about the submitter)     Permalink
      (Page 1 of 1 pages)
Related Topic(s): ; ; ; ; ; ; ; ; , Add Tags Add to My Group(s)

View Ratings | Rate It

opednews.com

- Advertisement -

Program Highlights Accomplishments of Company's Chief Scientific Officer and Blastomere Program

Advanced Cell Technology, Inc announced today that an ABC Televisions special report titled, Live to 150, Can You Do It? Secrets to Living Longer, which aired last night and was hosted by Barbara Walters, highlighted the role that the companys blastomere program for creating human embryonic stem cell (hESC) lines without impacting the developmental potential of embryos could play in extending life and slowing down the aging process.
- Advertisement -
The special highlighted Advanced Cell Technologys research into developing a universal O negative red blood cell bank using human embryonic stem cell science. The report, which included an interview with Dr. Robert Lanza, MD, Chief Scientific Officer at Advanced Cell Technology, featured the companys research platforms and included a discussion of the role that the companys stem cell science could play in treating various diseases.

The show profiled the lives of several people who are currently 100 years old or older and described some of the most promising scientific developments that could extend life. Advanced Cell Technologys technology platform was included among the scientific breakthroughs.

In August 2006, Advanced Cell Technology reported in the journal Nature that company scientists had successfully generated hESCs using its blastomere technology, an approach that does not destroy the developmental potential of embryos. The blastomere technology has been reproduced and peer-reviewed on several occasions. In June 2007, ACT announced at the fifth annual meeting of the International Society for Stem Cell Research in Cairns, Australia, that it had reproduced its work by successfully producing an hESC line without destroying an embryo at its lab in Worcester, Massachusetts.

In January 2008, ACT together with colleagues announced the development of five hESC lines without the destruction of embryos. The method was published in the journal Cell Stem Cells, published by Cell Press. The peer-reviewed technique was initially carried out by ACT scientists under the direction of Dr. Lanza and then independently replicated by scientists on the West Coast. In addition, the NIH announced in 2007 that it would begin implementing President George W. Bushs Executive Order to explore methods to expand the number of approved pluripotent stem cell lines without creating a human embryo for research purposes or destroying, discarding, or subjecting to harm a human embryo or fetus. ACTs blastomere program was cited by the NIH as an alternative method in its implementation plan; therefore, should the companys blastomere technique satisfy NIH qualifications, ACT could qualify for federal funding from the NIH.

- Advertisement -

In addition to its blastomere research platform, Advanced Cell Technology has made progress on the therapeutic front. ACT published positive data in the journal NATURE Methods for its HG (hemangioblast) cell program for the treatment of blood and cardiovascular diseases. The company published positive data from animal studies for its RPE (retinal pigment epithelial) cell program for the treatment of retinal degenerative disorders completed in collaboration with the Casey Eye Institute at Oregon Health and Science University.

Finally, ACTs Myoblast program, an autologous adult stem cell therapy for the treatment of heart disease, has successfully completed four Phase I clinical trials and has clearance from the FDA to begin Phase II trials shortly.

- Advertisement -

 

- Advertisement -

View Ratings | Rate It

/* The Petition Site */
The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact EditorContact Editor
- Advertisement -

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

NYC Council "STANDS UNITED" WITH N.DAKOTA PROTESTERS, 2 new videos of police using pepper spray and rubber bullets

Mirena Interuterine Devices can cause Depression, Mood swings, Acne, Back Pain, Uterine Cysts, and Uterine Perforations

CA Exit Polls reveal 23% Discrepancy; 11 States With Vote "Flipping" Evidence; Our New Directions in American History?

In the California Primary, More Ballots Remain Uncounted than the Total Number of votes for Hillary Clinton!

What does Coca Cola's Dasani bottled water have in common with Death by Lethal Injection?